HRS 2011: Which patients gain the most benefit from ablation therapy for AF?
Published
06 May 2011
| Article by Excerpta Medica
HRS 2011: Which patients gain the most benefit from ablation therapy for AF?
Analysis of data from a large German registry shows that patients with hypertensive heart disease (HHD) tend to have more benefit from ablation therapy for atrial fibrillation (AF) than those with hypertrophic cardiomyopathy (HCM).
To read the full article, please register for GetInsideHealth below.
Register for GetInsideHealth
GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.
Please fill in the form below to register.
Already Registered?
Please login using
form at top of page
Fields with an asterisk (*) are mandatory
About you
Login information
Newsletter
Additional information